• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

F-FDG PET/CT 在评估特发性肺纤维化患者疾病严重程度和预后中的价值。

The Value of F-FDG PET/CT in Evaluating Disease Severity and Prognosis in Idiopathic Pulmonary Fibrosis Patients.

机构信息

Department of Pulmonary and Critical Care Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.

Department of Nuclear Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.

出版信息

J Korean Med Sci. 2021 Oct 25;36(41):e257. doi: 10.3346/jkms.2021.36.e257.

DOI:10.3346/jkms.2021.36.e257
PMID:34697928
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8546311/
Abstract

BACKGROUND

Several parameters are useful for assessing disease severity in idiopathic pulmonary fibrosis (IPF); however, the role of F-fluorodeoxyglucose positron emission tomography/computed tomography (F-FDG PET/CT) is not well-defined. We aimed to evaluate the value of F-FDG PET/CT for assessing disease severity and prognosis in IPF patients.

METHODS

Clinical data of 89 IPF patients (mean age: 68.1 years, male: 94%) who underwent F-FDG PET/CT for evaluation of lung nodules or cancer staging were retrospectively reviewed. Mean and maximal standardized uptake values (SUV, SUV, respectively) were measured in the fibrotic area. Adjusted SUV, including SUV ratio (SUVR, defined as SUV-to-liver SUV ratio), tissue fraction-corrected SUV (SUV), and SUVR (SUVR), and tissue-to-blood ratio (SUV/SUV venous; TBR) were obtained. Death was defined as the primary outcome, and associations between other clinical parameters (lung function, exercise capacity, C-reactive protein [CRP] level) were also investigated.

RESULTS

All SUV parameters were inversely correlated with the forced vital capacity, diffusing capacity for carbon monoxide, and positively correlated with CRP level and the gender-age-physiology index. The SUV, SUV, and SUV were associated with changes in lung function at six months. The SUVR (hazard ratio [HR], 1.738; 95% confidence interval [CI], 1.011-2.991), SUVR (HR, 1.441; 95% CI, 1.000-2.098), and TBR (HR, 1.377; 95% CI, 1.038-1.827) were significant predictors for mortality in patients with IPF in the univariate analysis, but not in the multivariate analysis.

CONCLUSION

F-FDG PET/CT may provide additional information on the disease severity and prognosis in IPF patients, and the SUVR may be superior to other SUV parameters.

摘要

背景

评估特发性肺纤维化(IPF)疾病严重程度时,有多个参数可用;然而,氟-18 氟代脱氧葡萄糖正电子发射断层扫描/计算机断层扫描(F-FDG PET/CT)的作用尚未明确。我们旨在评估 F-FDG PET/CT 评估 IPF 患者疾病严重程度和预后的价值。

方法

回顾性分析了 89 例因肺结节或癌症分期而行 F-FDG PET/CT 评估的 IPF 患者的临床资料(平均年龄:68.1 岁,男性:94%)。在纤维化区域测量平均和最大标准化摄取值(SUV、SUV ,分别)。获得调整后的 SUV,包括 SUV 比(SUVR,定义为 SUV 与肝 SUV 比)、组织分数校正 SUV(SUV )和 SUVR(SUV )以及组织与血液比(SUV/SUV 静脉;TBR)。死亡定义为主要结局,还研究了其他临床参数(肺功能、运动能力、C 反应蛋白 [CRP] 水平)之间的关联。

结果

所有 SUV 参数均与用力肺活量、一氧化碳弥散量呈负相关,与 CRP 水平和性别-年龄-生理指数呈正相关。SUV、SUV 和 SUV 与 6 个月时肺功能变化相关。SUVR(风险比 [HR],1.738;95%置信区间 [CI],1.011-2.991)、SUVR(HR,1.441;95% CI,1.000-2.098)和 TBR(HR,1.377;95% CI,1.038-1.827)是单变量分析中 IPF 患者死亡的显著预测因子,但在多变量分析中并非如此。

结论

F-FDG PET/CT 可能为 IPF 患者的疾病严重程度和预后提供额外信息,而 SUVR 可能优于其他 SUV 参数。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/acb2/8546311/9770ff35854d/jkms-36-e257-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/acb2/8546311/c0bf83d952e3/jkms-36-e257-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/acb2/8546311/587b81aeeacd/jkms-36-e257-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/acb2/8546311/9770ff35854d/jkms-36-e257-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/acb2/8546311/c0bf83d952e3/jkms-36-e257-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/acb2/8546311/587b81aeeacd/jkms-36-e257-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/acb2/8546311/9770ff35854d/jkms-36-e257-g003.jpg

相似文献

1
The Value of F-FDG PET/CT in Evaluating Disease Severity and Prognosis in Idiopathic Pulmonary Fibrosis Patients.F-FDG PET/CT 在评估特发性肺纤维化患者疾病严重程度和预后中的价值。
J Korean Med Sci. 2021 Oct 25;36(41):e257. doi: 10.3346/jkms.2021.36.e257.
2
F-FDG PET/CT predicts acute exacerbation in idiopathic pulmonary fibrosis after thoracic surgery.氟代脱氧葡萄糖正电子发射断层扫描/计算机断层扫描预测特发性肺纤维化胸外科手术后的急性加重。
BMC Pulm Med. 2021 Sep 16;21(1):294. doi: 10.1186/s12890-021-01659-4.
3
[F]FDG PET/CT predicts progression-free survival in patients with idiopathic pulmonary fibrosis.[F]氟代脱氧葡萄糖正电子发射断层扫描/计算机断层扫描(FDG PET/CT)可预测特发性肺纤维化患者的无进展生存期。
Respir Res. 2017 Apr 27;18(1):74. doi: 10.1186/s12931-017-0556-3.
4
18F-FDG Uptake in Less Affected Lung Field Provides Prognostic Stratification in Patients with Interstitial Lung Disease.18F-FDG在间质性肺疾病患者病变较轻肺野的摄取情况可提供预后分层。
J Nucl Med. 2016 Dec;57(12):1899-1904. doi: 10.2967/jnumed.116.174946. Epub 2016 Jun 23.
5
Prognostic Value of Dual-Time-Point 18F-FDG PET for Idiopathic Pulmonary Fibrosis.双时相 18F-FDG PET 对特发性肺纤维化的预后价值。
J Nucl Med. 2015 Dec;56(12):1869-75. doi: 10.2967/jnumed.115.163360. Epub 2015 Sep 10.
6
Is F-FDG PET/CT useful for the differential diagnosis of solitary pulmonary nodules in patients with idiopathic pulmonary fibrosis?F-FDG PET/CT对特发性肺纤维化患者孤立性肺结节的鉴别诊断是否有用?
Ann Nucl Med. 2018 Aug;32(7):492-498. doi: 10.1007/s12149-018-1273-9. Epub 2018 Jul 4.
7
Pulmonary F-FDG uptake helps refine current risk stratification in idiopathic pulmonary fibrosis (IPF).肺 F-FDG 摄取有助于细化特发性肺纤维化 (IPF) 中的当前风险分层。
Eur J Nucl Med Mol Imaging. 2018 May;45(5):806-815. doi: 10.1007/s00259-017-3917-8. Epub 2018 Jan 16.
8
Synergistic application of pulmonary F-FDG PET/HRCT and computer-based CT analysis with conventional severity measures to refine current risk stratification in idiopathic pulmonary fibrosis (IPF).肺 F-FDG PET/HRCT 与基于计算机的 CT 分析协同应用于传统严重程度测量,以完善特发性肺纤维化(IPF)当前的风险分层。
Eur J Nucl Med Mol Imaging. 2019 Sep;46(10):2023-2031. doi: 10.1007/s00259-019-04386-5. Epub 2019 Jul 8.
9
Intra-tumor metabolic heterogeneity of gastric cancer on F-FDG PETCT indicates patient survival outcomes.胃癌在F-FDG PETCT上的肿瘤内代谢异质性预示患者生存结局。
Clin Exp Med. 2021 Feb;21(1):129-138. doi: 10.1007/s10238-020-00659-8. Epub 2020 Sep 3.
10
Can FDG-PET/CT imaging be used to predict decline in quality of life in interstitial lung disease? A prospective study of the relationship between FDG uptake and quality of life in a UK outpatient setting.FDG-PET/CT 成像能否用于预测间质性肺疾病患者生活质量下降?一项英国门诊环境中 FDG 摄取与生活质量关系的前瞻性研究。
BMJ Open. 2024 May 30;14(5):e081103. doi: 10.1136/bmjopen-2023-081103.

引用本文的文献

1
Imaging in animal models: bridging experimental findings and human pathophysiology.动物模型中的成像:连接实验结果与人类病理生理学
Crit Care. 2025 Jul 26;29(1):327. doi: 10.1186/s13054-025-05574-6.
2
The value of fibrosis score and F-FDG by positron emission tomography-computed tomography in lung cancer patients with interstitial lung disease.肺癌合并间质性肺疾病患者的纤维化评分及正电子发射断层扫描-计算机断层扫描F-FDG的价值
J Thorac Dis. 2025 Mar 31;17(3):1541-1551. doi: 10.21037/jtd-24-1512. Epub 2025 Mar 10.
3
Targeted imaging of pulmonary fibrosis by a cyclic peptide LyP-1.

本文引用的文献

1
Prognostic impact of malignant diseases in idiopathic pulmonary fibrosis.特发性肺纤维化中恶性疾病的预后影响。
Sci Rep. 2020 Oct 26;10(1):18260. doi: 10.1038/s41598-020-75276-2.
2
Korean Guidelines for Diagnosis and Management of Interstitial Lung Diseases: Part 2. Idiopathic Pulmonary Fibrosis.韩国间质性肺疾病诊断与管理指南:第2部分。特发性肺纤维化
Tuberc Respir Dis (Seoul). 2019 Apr;82(2):102-117. doi: 10.4046/trd.2018.0091. Epub 2019 Feb 28.
3
Variations of the liver standardized uptake value in relation to background blood metabolism: An 2-[18F]Fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography study in a large population from China.
环肽LyP-1对肺纤维化的靶向成像
Sci Rep. 2025 Mar 8;15(1):8098. doi: 10.1038/s41598-024-78068-0.
4
Molecular Imaging of Pulmonary Fibrosis.肺纤维化的分子成像
J Nucl Med. 2025 Apr 1;66(4):502-505. doi: 10.2967/jnumed.124.267852.
5
Mortality-related risk factors of idiopathic pulmonary fibrosis: a systematic review and meta-analysis.特发性肺纤维化的死亡相关危险因素:一项系统评价与荟萃分析
J Thorac Dis. 2024 Dec 31;16(12):8338-8349. doi: 10.21037/jtd-23-1908. Epub 2024 Dec 20.
6
Pulmonary fibrosis: pathogenesis and therapeutic strategies.肺纤维化:发病机制与治疗策略。
MedComm (2020). 2024 Sep 23;5(10):e744. doi: 10.1002/mco2.744. eCollection 2024 Oct.
7
Predictors for acute exacerbation of interstitial pneumonia following lung cancer surgery: a multicenter study.肺癌手术后间质性肺炎急性加重的预测因素:一项多中心研究。
BMC Pulm Med. 2024 Aug 1;24(1):377. doi: 10.1186/s12890-024-03177-5.
8
Can FDG-PET/CT imaging be used to predict decline in quality of life in interstitial lung disease? A prospective study of the relationship between FDG uptake and quality of life in a UK outpatient setting.FDG-PET/CT 成像能否用于预测间质性肺疾病患者生活质量下降?一项英国门诊环境中 FDG 摄取与生活质量关系的前瞻性研究。
BMJ Open. 2024 May 30;14(5):e081103. doi: 10.1136/bmjopen-2023-081103.
9
Tc-Labeled FAPI SPECT Imaging in Idiopathic Pulmonary Fibrosis: Preliminary Results.锝标记的纤维连接蛋白激活肽单光子发射计算机断层扫描成像在特发性肺纤维化中的应用:初步结果
Pharmaceuticals (Basel). 2023 Oct 9;16(10):1434. doi: 10.3390/ph16101434.
10
Prone position PET/CT is useful in reducing gravity-dependent opacity-related [F]fluorodeoxyglucose uptake.俯卧位 PET/CT 有助于减少与重力相关的不透明性有关的 [F]氟脱氧葡萄糖摄取。
Eur Radiol. 2023 Nov;33(11):8270-8278. doi: 10.1007/s00330-023-09831-6. Epub 2023 Jun 16.
肝脏标准化摄取值与背景血液代谢的关系:一项在中国大量人群中进行的2-[18F]氟-2-脱氧-D-葡萄糖正电子发射断层扫描/计算机断层扫描研究。
Medicine (Baltimore). 2018 May;97(19):e0699. doi: 10.1097/MD.0000000000010699.
4
Low diffusing capacity, emphysema, or pulmonary fibrosis: who is truly pulling the lung cancer strings?低弥散能力、肺气肿或肺纤维化:究竟是谁在真正操控肺癌?
J Thorac Dis. 2018 Feb;10(2):600-602. doi: 10.21037/jtd.2017.12.145.
5
Pulmonary F-FDG uptake helps refine current risk stratification in idiopathic pulmonary fibrosis (IPF).肺 F-FDG 摄取有助于细化特发性肺纤维化 (IPF) 中的当前风险分层。
Eur J Nucl Med Mol Imaging. 2018 May;45(5):806-815. doi: 10.1007/s00259-017-3917-8. Epub 2018 Jan 16.
6
[F]FDG PET/CT predicts progression-free survival in patients with idiopathic pulmonary fibrosis.[F]氟代脱氧葡萄糖正电子发射断层扫描/计算机断层扫描(FDG PET/CT)可预测特发性肺纤维化患者的无进展生存期。
Respir Res. 2017 Apr 27;18(1):74. doi: 10.1186/s12931-017-0556-3.
7
18F-FDG Uptake in Less Affected Lung Field Provides Prognostic Stratification in Patients with Interstitial Lung Disease.18F-FDG在间质性肺疾病患者病变较轻肺野的摄取情况可提供预后分层。
J Nucl Med. 2016 Dec;57(12):1899-1904. doi: 10.2967/jnumed.116.174946. Epub 2016 Jun 23.
8
Acute Exacerbation of Idiopathic Pulmonary Fibrosis. An International Working Group Report.特发性肺纤维化急性加重:国际工作组报告。
Am J Respir Crit Care Med. 2016 Aug 1;194(3):265-75. doi: 10.1164/rccm.201604-0801CI.
9
Effect of continued treatment with pirfenidone following clinically meaningful declines in forced vital capacity: analysis of data from three phase 3 trials in patients with idiopathic pulmonary fibrosis.特发性肺纤维化患者用力肺活量出现具有临床意义的下降后继续使用吡非尼酮治疗的效果:来自三项3期试验的数据分析
Thorax. 2016 May;71(5):429-35. doi: 10.1136/thoraxjnl-2015-207011. Epub 2016 Mar 11.
10
An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline: Treatment of Idiopathic Pulmonary Fibrosis. An Update of the 2011 Clinical Practice Guideline.美国胸科学会/欧洲呼吸学会/日本呼吸学会/拉丁美洲胸科学会特发性肺纤维化临床实践指南:治疗。对 2011 年临床实践指南的更新。
Am J Respir Crit Care Med. 2015 Jul 15;192(2):e3-19. doi: 10.1164/rccm.201506-1063ST.